NATCO PHARMA
Back to All Ratios
|
NATCO PHARMA Last 5 Year EV/Core EBITDA History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| EV/Core EBITDA(x) | 4.85 | 8.75 | 9.52 | 38.67 | 21.19 |
What is the latest EV/Core EBITDA ratio of NATCO PHARMA ?
| Year | EV/Core EBITDA |
|---|---|
| Mar2025 | 4.85 |
| Mar2024 | 8.75 |
| Mar2023 | 9.52 |
| Mar2022 | 38.67 |
| Mar2021 | 21.19 |
How is EV/Core EBITDA of NATCO PHARMA Trending?
| Years | EV/Core EBITDA | % Change | |
|---|---|---|---|
| Mar2025 | 4.85 | -44.57 | |
| Mar2024 | 8.75 | -8.09 | |
| Mar2023 | 9.52 | -75.38 | |
| Mar2022 | 38.67 | 82.49 | |
| Mar2021 | 21.19 | - | |
Other Financial Ratios of NATCO PHARMA
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/Core EBITDA ratio of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹20,960.1 Cr | -2.1% | 11.1% | 37.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,725.0 Cr | 0.6% | 13.6% | 8.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,775.0 Cr | 1.5% | 9.1% | 9.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,764.0 Cr | 1.5% | 8.2% | 35.7% | Stock Analytics | |
| CIPLA | ₹113,007.0 Cr | -2.1% | 13.7% | -6.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,098.0 Cr | -1.4% | 8% | 7.4% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | -2.1% |
11.1% |
37.3% |
| SENSEX | 0.2% |
-4.9% |
-8.4% |
You may also like the below Video Courses